[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053702":3},{"organization":4,"armGroups":7,"interventions":41,"overallOfficials":48,"centralContacts":53,"locations":62,"responsibleParty":260,"collaborators":47,"id":262,"slug":263,"hasResults":264,"nctId":265,"briefTitle":266,"officialTitle":267,"acronym":47,"eligibilityCriteria":268,"healthyVolunteers":264,"sex":269,"minAge":270,"maxAge":271,"enrollmentInfo":272,"targetDuration":47,"studyType":275,"phases":276,"briefSummary":278,"conditions":279,"keywords":282,"overallStatus":65,"whyStopped":47,"lastUpdateSubmitDate":289,"lastUpdatePostDateStruct":290,"startDateStruct":293,"completionDateStruct":295,"leadSponsor":297,"locationsCount":298},{"fullName":5,"class":6},"Verve Therapeutics, Inc.","INDUSTRY",[8,14,17,20,23,26,29,32,35,38],{"label":9,"type":10,"description":11,"interventionNames":12},"Cohort 1: Single Ascending Dose Escalation","EXPERIMENTAL","Participants will receive a single dose of VERVE-102.",[13],"Drug: VERVE-102",{"label":15,"type":10,"description":11,"interventionNames":16},"Cohort 2: Single Ascending Dose Escalation",[13],{"label":18,"type":10,"description":11,"interventionNames":19},"Cohort 3: Single Ascending Dose Escalation",[13],{"label":21,"type":10,"description":11,"interventionNames":22},"Cohort 4: Single Ascending Dose Escalation",[13],{"label":24,"type":10,"description":11,"interventionNames":25},"Cohort 5: Single Ascending Dose Escalation",[13],{"label":27,"type":10,"description":11,"interventionNames":28},"Cohort 6: Single Ascending Dose Escalation",[13],{"label":30,"type":10,"description":11,"interventionNames":31},"Cohort 7: Single Ascending Dose Escalation",[13],{"label":33,"type":10,"description":11,"interventionNames":34},"Cohort 8: Single Ascending Dose Escalation",[13],{"label":36,"type":10,"description":11,"interventionNames":37},"Cohort 9: Single Fixed Dose",[13],{"label":39,"type":10,"description":11,"interventionNames":40},"Cohort 10: Single Fixed Dose",[13],[42],{"type":43,"name":44,"description":45,"armGroupLabels":46,"otherNames":47},"DRUG","VERVE-102","Intravenous (IV) infusion",[39,9,15,18,21,24,27,30,33,36],null,[49],{"name":50,"affiliation":51,"role":52},"Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC\u002FGMT - 5 hours, EST)","Eli Lilly and Company","STUDY_DIRECTOR",[54,59],{"name":55,"role":56,"phone":57,"phoneExt":47,"email":58},"Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or","CONTACT","317-615-4559","LillyTrials@Lilly.com",{"name":60,"role":56,"phone":47,"phoneExt":47,"email":61},"Physicians interested in becoming principal investigators please contact","clinical_inquiry_hub@lilly.com",[63,77,86,95,103,111,120,129,138,147,154,161,170,177,184,191,198,205,214,223,232,239,246,253],{"facility":64,"status":65,"city":66,"state":67,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":47},"Clinical Study Center","RECRUITING","Dothan","Alabama","36305","United States","US",{"type":72,"coordinates":73},"Point",[74,75],-85.39049,31.22323,{"lat":75,"lon":74},{"facility":64,"status":65,"city":78,"state":79,"zip":80,"country":69,"countryCode":70,"cosmosGeoPoint":81,"geoPoint":85,"contacts":47},"Pomona","California","91768",{"type":72,"coordinates":82},[83,84],-117.75228,34.05529,{"lat":84,"lon":83},{"facility":64,"status":65,"city":87,"state":88,"zip":89,"country":69,"countryCode":70,"cosmosGeoPoint":90,"geoPoint":94,"contacts":47},"Boca Raton","Florida","33434",{"type":72,"coordinates":91},[92,93],-80.0831,26.35869,{"lat":93,"lon":92},{"facility":64,"status":65,"city":96,"state":88,"zip":97,"country":69,"countryCode":70,"cosmosGeoPoint":98,"geoPoint":102,"contacts":47},"Jacksonville","32216",{"type":72,"coordinates":99},[100,101],-81.65565,30.33218,{"lat":101,"lon":100},{"facility":64,"status":65,"city":104,"state":88,"zip":105,"country":69,"countryCode":70,"cosmosGeoPoint":106,"geoPoint":110,"contacts":47},"Winter Park","32789",{"type":72,"coordinates":107},[108,109],-81.33924,28.6,{"lat":109,"lon":108},{"facility":64,"status":65,"city":112,"state":113,"zip":114,"country":69,"countryCode":70,"cosmosGeoPoint":115,"geoPoint":119,"contacts":47},"High Point","North Carolina","27260",{"type":72,"coordinates":116},[117,118],-80.00532,35.95569,{"lat":118,"lon":117},{"facility":64,"status":65,"city":121,"state":122,"zip":123,"country":69,"countryCode":70,"cosmosGeoPoint":124,"geoPoint":128,"contacts":47},"DeSoto","Texas","75115",{"type":72,"coordinates":125},[126,127],-96.85695,32.58986,{"lat":127,"lon":126},{"facility":64,"status":65,"city":130,"state":131,"zip":132,"country":69,"countryCode":70,"cosmosGeoPoint":133,"geoPoint":137,"contacts":47},"Renton","Washington","98057",{"type":72,"coordinates":134},[135,136],-122.21707,47.48288,{"lat":136,"lon":135},{"facility":64,"status":65,"city":139,"state":47,"zip":47,"country":140,"countryCode":141,"cosmosGeoPoint":142,"geoPoint":146,"contacts":47},"Adelaide","Australia","AU",{"type":72,"coordinates":143},[144,145],138.59863,-34.92866,{"lat":145,"lon":144},{"facility":64,"status":65,"city":148,"state":47,"zip":47,"country":140,"countryCode":141,"cosmosGeoPoint":149,"geoPoint":153,"contacts":47},"Melbourne",{"type":72,"coordinates":150},[151,152],144.96332,-37.814,{"lat":152,"lon":151},{"facility":64,"status":65,"city":155,"state":47,"zip":47,"country":140,"countryCode":141,"cosmosGeoPoint":156,"geoPoint":160,"contacts":47},"Sydney",{"type":72,"coordinates":157},[158,159],151.20732,-33.86785,{"lat":159,"lon":158},{"facility":64,"status":65,"city":162,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":165,"geoPoint":169,"contacts":47},"Chicoutimi","Canada","CA",{"type":72,"coordinates":166},[167,168],-71.06369,48.41963,{"lat":168,"lon":167},{"facility":64,"status":65,"city":171,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":172,"geoPoint":176,"contacts":47},"Hamilton",{"type":72,"coordinates":173},[174,175],-79.84963,43.25011,{"lat":175,"lon":174},{"facility":64,"status":65,"city":178,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":179,"geoPoint":183,"contacts":47},"Montreal",{"type":72,"coordinates":180},[181,182],-73.58781,45.50884,{"lat":182,"lon":181},{"facility":64,"status":65,"city":185,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":186,"geoPoint":190,"contacts":47},"Québec",{"type":72,"coordinates":187},[188,189],-71.21454,46.81228,{"lat":189,"lon":188},{"facility":64,"status":65,"city":192,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":193,"geoPoint":197,"contacts":47},"Toronto",{"type":72,"coordinates":194},[195,196],-79.39864,43.70643,{"lat":196,"lon":195},{"facility":64,"status":65,"city":199,"state":47,"zip":47,"country":163,"countryCode":164,"cosmosGeoPoint":200,"geoPoint":204,"contacts":47},"Vancouver",{"type":72,"coordinates":201},[202,203],-123.11934,49.24966,{"lat":203,"lon":202},{"facility":64,"status":65,"city":206,"state":47,"zip":47,"country":207,"countryCode":208,"cosmosGeoPoint":209,"geoPoint":213,"contacts":47},"Rehovot","Israel","IL",{"type":72,"coordinates":210},[211,212],34.81199,31.89421,{"lat":212,"lon":211},{"facility":64,"status":65,"city":215,"state":47,"zip":47,"country":216,"countryCode":217,"cosmosGeoPoint":218,"geoPoint":222,"contacts":47},"Christchurch","New Zealand","NZ",{"type":72,"coordinates":219},[220,221],172.63333,-43.53333,{"lat":221,"lon":220},{"facility":64,"status":65,"city":224,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":227,"geoPoint":231,"contacts":47},"Birmingham","United Kingdom","UK",{"type":72,"coordinates":228},[229,230],-1.89983,52.48142,{"lat":230,"lon":229},{"facility":64,"status":65,"city":233,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":234,"geoPoint":238,"contacts":47},"Edinburgh",{"type":72,"coordinates":235},[236,237],-3.19648,55.95206,{"lat":237,"lon":236},{"facility":64,"status":65,"city":240,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":241,"geoPoint":245,"contacts":47},"London",{"type":72,"coordinates":242},[243,244],-0.12574,51.50853,{"lat":244,"lon":243},{"facility":64,"status":65,"city":247,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":248,"geoPoint":252,"contacts":47},"Manchester",{"type":72,"coordinates":249},[250,251],-2.23743,53.48095,{"lat":251,"lon":250},{"facility":64,"status":65,"city":254,"state":47,"zip":47,"country":225,"countryCode":226,"cosmosGeoPoint":255,"geoPoint":259,"contacts":47},"Nottingham",{"type":72,"coordinates":256},[257,258],-1.15047,52.9536,{"lat":258,"lon":257},{"type":261,"investigatorFullName":47,"investigatorTitle":47,"investigatorAffiliation":47,"oldNameTitle":47,"oldOrganization":47},"SPONSOR","100053702","phase-1-a-study-of-verve-102-in-patients-with-familial-hypercholesterolemia-or-premature-coronary-artery-disease-100053702",false,"NCT06164730","A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease","Open-label, Phase 1b, Single Ascending Dose Study to Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia or Premature Coronary Artery Disease Who Require Additional Lowering of Low-density Lipoprotein Cholesterol","Inclusion Criteria:\n\n* Diagnosis of HeFH or premature CAD\n\nExclusion Criteria:\n\n* Homozygous familial hypercholesterolemia\n* Active or history of chronic liver disease\n* Current treatment with PCSK9 inhibitor or prior treatment within specified timeframe\n* Clinically significant or abnormal laboratory values as defined by the protocol","ALL","18 Years","70 Years",{"count":273,"type":274},85,"ESTIMATED","INTERVENTIONAL",[277],"PHASE1","VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating PCSK9 and LDL-C. This Study is Designed to Determine the Safety and Pharmacodynamic Profile of VERVE-102 in This Patient Population.",[280,281],"Heterozygous Familial Hypercholesterolemia","Premature Coronary Heart Disease",[44,283,284,285,286,287,288],"Familial Hypercholesterolemia","Coronary Artery Disease","Dose Escalation","Gene Editing","Base Editing","heart-2","2026-07-10",{"date":291,"type":292},"2026-07-13","ACTUAL",{"date":294,"type":292},"2024-04-30",{"date":296,"type":274},"2027-08",{"name":5,"class":6},24]